Chip, pharma IPOs need subsidy scrutiny, China antitrust advisor says
A top antitrust advisor to China's State Council, the country's cabinet, is recommending semiconductor and pharmaceutical companies be required to disclose plans for reducing reliance on government subsidies before going public. Huang...To view the full article, register now.
Already a subscriber? Click here to view full article